NanoKnife series published in EUO

12 May 2019

Recently European Urology Oncology accepted the publication of the largest focal NanoKnife therapy group in the world.

The article: Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort. Eur Urol Oncol (2019), looked at 123 patients all with MRI followup and biopsy followup with a minimum of one year follow up. This series showed a 97% clearance of cancer infield and a 10% to 12% chance of recurrence in the outfield. This is part of the 300 cases performed by Professor Stricker to date.

Key aspects

From diagnosis and treatment to rehabilitation and research, I believe my highly experienced team and I bring a multifaceted approach to understanding and helping our patients. A summary of these key aspects of that approach is available here in PDF format. If you are suffering from prostate cancer or have reason to believe you might be, you are welcome to contact us or, intially, complete our comprehensive second opinion form.